Acute Kidney Injury in Adult Patients Supported by VA-ECMO (NCT04082312) | Clinical Trial Compass
CompletedNot Applicable
Acute Kidney Injury in Adult Patients Supported by VA-ECMO
France347 participantsStarted 2016-05-01
Plain-language summary
Post-cardiotomy cardiogenic shock (PCCS) occurs in 2-6% of patients undergoing cardiac surgery, and 1% of cardiac surgery patients will require mechanical circulatory support using Veno-Arterial ExtraCorporeal Membrane Oxygenation (VA-ECMO). Acute Kidney Injury is a frequent complication in this population and negatively impacts the survival. We aimed to determine whether the timing of ECMO implantation influence the renal prognosis of these patients.
Who can participate
Age range
18 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All patients admitted in post-operative of cardiac surgery
* Assisted by VA-ECMO
Exclusion Criteria:
* Chronic hemodialysis
* Death occurring within the first 48 hours of VA-ECMO implantation
* Multiple VA-ECMO during the same hospitalization.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on stage 3 acute kidney injury in patients on VA-ECMO for cardiogenic shock — based on what this study found, how does being on VA-ECMO affect the risk of severe kidney injury, and does that change how my kidneys would be monitored if I needed this type of support?
2Since this study is now completed, has my care team seen or reviewed its findings, and do those results influence the way they would manage kidney function in my specific situation?
3The trial looked at patients with both cardiogenic shock and acute kidney injury — given my own kidney health going into treatment, how would my doctors track for early warning signs of kidney decline if VA-ECMO becomes part of my care?
4If severe kidney injury, like what this study was measuring, does occur during VA-ECMO support, what are the treatment options available at this point, and at what stage would the team consider something like dialysis?
5Are there approaches or protocols now in place — possibly informed by studies like this one — that are specifically designed to protect kidney function in patients who need VA-ECMO, and would those apply to my care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.